Fragile X webinar, 18/10/2021, online via zoom
Join a 1-hour webinar for ongoing research in FXS and information on clinical trials now recruiting. Dr Elizabeth Berry-Kravis, Dr Georgios Drakakis, and Michael Trafaglia, MD CSO of FRAXA will present new findings and expected results. Dr Georgios Drakakis will explain the steps followed by Purposeful that led to a fast-track proof-of-concept trial and the promise of combination trials. Discussion on the support and awareness as well as the importance of clinical trials participation together with any technical issues that often arise.